SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2024 9.795M
December 31, 2023 10.09M
June 30, 2023 8.437M
December 31, 2022 10.50M
June 30, 2022 11.15M
Date Value
December 31, 2021 8.047M
June 30, 2021 8.334M
December 31, 2020 9.706M
June 30, 2020 5.028M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
InflaRx NV 16.14M
BioNTech SE 833.57M
Immatics NV 63.90M
Arrowhead Pharmaceuticals, Inc. 172.57M
Oncolytics Biotech, Inc. 16.62M